1. Fangchinoline abrogates growth and survival of hepatocellular carcinoma by negative regulation of c‐met/HGF and its associated downstream signaling pathways
    Young Yun Jung et al, 2022, Phytotherapy Research CrossRef
  2. Molecular targets and anticancer potential of evodiamine
    Yangyang Wang et al, 2022, Phytochemistry Letters CrossRef
  3. Fangchinoline diminishes STAT3 activation by stimulating oxidative stress and targeting SHP-1 protein in multiple myeloma model
    Young Yun Jung et al, 2022, Journal of Advanced Research CrossRef
  4. Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models
    Myriam Mérarchi et al, 2018, Molecules CrossRef
  5. Fangchinoline Inhibits Human Esophageal Cancer by Transactivating ATF4 to Trigger Both Noxa-Dependent Intrinsic and DR5-Dependent Extrinsic Apoptosis
    Yunjing Zhang et al, 2021, Frontiers in Oncology CrossRef
  6. Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis
    Jiandong Li et al, 2022, PLOS ONE CrossRef
  7. Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer
    Jia-shu Chen et al, 2023, Bioorganic Chemistry CrossRef
  8. Fangchinoline alleviates cognitive impairments through enhancing autophagy and mitigating oxidative stress in Alzheimer’s disease models
    Lilin Yi et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
  9. Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways
    Young Yun Jung et al, 2019, Molecules CrossRef
  10. Fangchinoline Has an Anti-Arthritic Effect in Two Animal Models and in IL-1β-Stimulated Human FLS Cells
    Thea Villa et al, 2020, Biomolecules & Therapeutics CrossRef
  11. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
    Mehrdokht Sadrkhanloo et al, 2023, Pathology - Research and Practice CrossRef
  12. Network Pharmacology and Molecular Docking Integrated Strategy to the Screening of Active Components and Mechanisms of Stephaniae Tetrandrae Radix on Breast Cancer
    Kaiyue Wang et al, 2022, Processes CrossRef
  13. Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase
    Wangming Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  14. A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji)
    Yueping Jiang et al, 2020, Phytochemistry Reviews CrossRef
  15. Novel Aurora A Kinase Inhibitor Fangchinoline Enhances Cisplatin–DNA Adducts and Cisplatin Therapeutic Efficacy in OVCAR-3 Ovarian Cancer Cells-Derived Xenograft Model
    Daniel Winardi et al, 2022, International Journal of Molecular Sciences CrossRef
  16. Fangchinoline inhibits the PEDV replication in intestinal epithelial cells via autophagic flux suppression
    Weixiao Zhang et al, 2023, Frontiers in Microbiology CrossRef
  17. Fangchinoline targets epithelial–mesenchymal transition process by modulating activation of multiple cell‐signaling pathways
    Young Y. Jung et al, 2022, Journal of Cellular Biochemistry CrossRef